Drug Shortage Report for MAXALT RPD

Last updated on 2023-04-05 History
Report ID 187527
Drug Identification Number 02240519
Brand name MAXALT RPD
Common or Proper name rizatriptan benzoate wafers
Company Name ORGANON CANADA INC.
Market Status MARKETED
Active Ingredient(s) RIZATRIPTAN
Strength(s) 10MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL ORAL
Packaging size 12
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2023-03-20
Estimated end date 2023-04-14
Actual end date 2023-04-04
Shortage status Resolved
Updated date 2023-04-05
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 16766 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-844-820-5468 dpoc.canada@organon.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2023-04-05 English Compare
v11 2023-04-04 French Compare
v10 2023-04-04 English Compare
v9 2023-03-21 English Compare
v8 2023-03-20 French Compare
v7 2023-03-20 English Compare
v6 2023-03-20 French Compare
v5 2023-03-20 English Compare
v4 2023-03-20 French Compare
v3 2023-03-20 French Compare
v2 2023-03-20 English Compare
v1 2023-03-20 English Compare

Showing 1 to 12 of 12